Epizyme, Inc. Insider Trading for June 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Epizyme, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Epizyme, Inc. for June 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 25 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Option Exercise | M | 0.60 | 13,450 | 8,070 | 96,314 | |
| Jun 25 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Option Exercise | M | 0.51 | 6,550 | 3,341 | 1,250 | |
| Jun 25 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 28.88 | 5,184 | 149,715 | 5,305 | 10.5 K to 5.3 K (-49.42 %) |
| Jun 25 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 28.26 | 14,816 | 418,697 | 10,489 | 25.3 K to 10.5 K (-58.55 %) |
| Jun 25 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Buy | M | 0.60 | 13,450 | 8,070 | 25,305 | 11.9 K to 25.3 K (+113.45 %) |
| Jun 25 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Buy | M | 0.51 | 6,550 | 3,341 | 11,855 | 5.3 K to 11.9 K (+123.47 %) |
| Jun 18 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Option Exercise | M | 2.19 | 2,000 | 4,380 | 284,500 | |
| Jun 18 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Sell | S | 26.42 | 2,000 | 52,840 | 0 | 2 K to 0 (-100.00 %) |
| Jun 18 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Buy | M | 2.19 | 2,000 | 4,380 | 2,000 | 0 to 2 K |
| Jun 18 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 26.38 | 12,756 | 336,540 | 5,525 | 18.3 K to 5.5 K (-69.78 %) |
| Jun 18 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 26.38 | 12,256 | 323,349 | 5,305 | 17.6 K to 5.3 K (-69.79 %) |
| Jun 11 2014 | EPZM | Epizyme, Inc. | Allen Andrew R | Director | Option Exercise | A | 24.29 | 17,666 | 429,107 | 17,666 | |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Option Exercise | M | 0.51 | 38,400 | 19,584 | 7,800 | |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 23.21 | 3,100 | 71,950 | 17,561 | 20.7 K to 17.6 K (-15.00 %) |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 22.21 | 35,300 | 784,115 | 20,661 | 56 K to 20.7 K (-63.08 %) |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Buy | M | 0.51 | 38,400 | 19,584 | 55,961 | 17.6 K to 56 K (+218.67 %) |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Option Exercise | M | 0.51 | 27,000 | 13,770 | 225,459 | |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Option Exercise | M | 3.54 | 15,000 | 53,100 | 208,833 | |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Sell | S | 23.36 | 1,264 | 29,529 | 58,000 | 59.3 K to 58 K (-2.13 %) |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Sell | S | 22.14 | 28,736 | 636,341 | 59,264 | 88 K to 59.3 K (-32.65 %) |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Buy | M | 0.51 | 27,000 | 13,770 | 88,000 | 61 K to 88 K (+44.26 %) |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Buy | M | 3.54 | 15,000 | 53,100 | 61,000 | 46 K to 61 K (+32.61 %) |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Option Exercise | M | 0.51 | 30,000 | 15,300 | 717,223 | |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Sell | S | 23.34 | 1,200 | 28,011 | 0 | 1.2 K to 0 (-100.00 %) |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Sell | S | 22.15 | 28,800 | 638,050 | 1,200 | 30 K to 1.2 K (-96.00 %) |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Buy | M | 0.51 | 30,000 | 15,300 | 30,000 | 0 to 30 K |